Kyndryl Files Amended Reports, Internal Controls Ineffective
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy KD?
Kyndryl filed two amended quarterly reports and one amended annual report providing further detail about problems reported on February 9. The recent filings reveal that "the company's disclosure controls and procedures and internal control over financial reporting were ineffective" as of March 31, June 30, and September 30, 2025. Each specified that "senior finance executives failed to set an appropriate tone at the top[.]" In addition, Kyndryl said "there was a lack of transparency with the company's CEO, the Audit Committee of the Board and the Board such that disclosure processes, including with respect to cash management practices regarding deferring vendor payments quarter to quarter, were impacted." The developments come after investors saw Kyndryl shares crater 55% on February 9, after the company announced that it would not timely file its quarterly report for the quarter ended December 31, 2025, anticipated reporting material internal control weaknesses, suffered C-Suite abrupt departures, and has come under SEC scrutiny. A securities class action lawsuit is pending and seeks to represent investors who purchased or otherwise acquired Kyndryl securities between August 7, 2024 and February 9, 2026. These developments and severe market reaction have prompted national shareholder rights law firm Hagens Berman to continue its investigation into claims that Kyndryl violated the federal securities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.080
Low
28.00
Averages
33.25
High
40.00
Current: 13.080
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kyndryl Faces Class Action Lawsuit, Shares Plunge 55%
- Lawsuit Notification: Kahn Swick & Foti LLC has informed Kyndryl investors of a class action lawsuit due to alleged securities fraud affecting investors from August 7, 2024, to February 9, 2026, seeking to recover losses.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls, which raises concerns about financial transparency.
- Executive Departures Impact: The departure of Kyndryl's CFO and General Counsel has exacerbated investor worries regarding corporate governance and financial health, leading to a decline in market confidence.
- Stock Price Plunge: Following the news of the lawsuit and financial issues, Kyndryl's stock price plummeted by 55%, dropping $12.90 per share to close at $10.59, reflecting a pessimistic outlook among investors regarding the company's future prospects.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation is facing a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant capital expenditure increases, which could severely impact its debt and credit rating, with investor losses expected to exceed $50,000.
- Paysafe Risks: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client in its e-commerce business, which is likely to negatively impact its revenue growth and may prevent it from meeting its financial guidance for fiscal year 2025.
- Inovio Pharmaceuticals Issues: Inovio Pharmaceuticals, Inc. is facing a class action lawsuit for the period from October 10, 2023, to December 26, 2025, due to deficiencies in manufacturing its CELLECTRA device, which is expected to hinder its ability to submit the INO-3107 BLA to the FDA by the second half of 2024, affecting its regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings, Inc. is being sued for the period from August 7, 2024, to February 9, 2026, due to materially misstated financial statements, which are expected to prevent timely filing of its Quarterly Report for the quarter ended December 31, 2025, raising concerns about its business outlook.
See More
Kyndryl Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Kyndryl, alleging securities fraud by the company and certain executives, with investors needing to apply as lead plaintiffs by April 13, 2026, indicating significant legal risks for the firm.
- Delayed Financial Reporting: On February 9, 2026, Kyndryl notified the SEC via Form 12b-5 that it could not file its 10-Q report for Q4 2025 on time, revealing an ongoing investigation into its financial reporting, which could undermine investor confidence.
- Frequent Executive Changes: On the same day, Kyndryl announced the immediate departures of CFO David Wyshner and General Counsel Edward Sebold, along with a role change for Senior VP Vineet Khurana, suggesting potential instability in the company's strategic direction due to high turnover.
- Stock Price Plummets: Following these announcements, Kyndryl's stock price fell by $12.90, or 55%, closing at $10.59 per share, reflecting extreme pessimism in the market regarding the company's future prospects, which may adversely affect its financing and operational capabilities.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, including inadequate internal controls, which led to the inability to timely file its Quarterly Report for the quarter ending December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong reputation in the field.
- Investor Selection Advice: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation in the class action.
See More
Kyndryl Holdings Shareholder Class Action Notice
- Class Action Notice: The Gross Law Firm has issued a notice to shareholders of Kyndryl Holdings, Inc. (NYSE:KD), encouraging those who purchased shares during the class period from August 7, 2024, to February 9, 2026, to contact the firm regarding potential lead plaintiff appointment for recovery.
- Financial Misstatements: The complaint alleges that Kyndryl's financial statements during the class period were materially misstated and that the company failed to disclose inadequate internal controls, which resulted in the inability to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025, undermining investor confidence in the company's prospects.
- Registration Deadline: Shareholders must register by April 13, 2026, to participate in the class action, and upon registration, they will be enrolled in a portfolio monitoring software to receive status updates throughout the case lifecycle, ensuring investors stay informed.
- Law Firm Background: The Gross Law Firm is a nationally recognized class action law firm committed to protecting the rights of investors who have suffered losses due to deceit and illegal business practices, emphasizing the importance of responsible business practices and good corporate citizenship.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, lacked adequate internal controls, and failed to timely file its Quarterly Report for the quarter ending December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
Kyndryl Faces Class Action Lawsuit, Shares Plunge 55%
- Lawsuit Notification: Kahn Swick & Foti LLC has informed Kyndryl investors of a class action lawsuit due to alleged securities fraud affecting investors from August 7, 2024, to February 9, 2026, seeking to recover losses.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls, which raises concerns about financial transparency.
- Executive Departures Impact: The departure of Kyndryl's CFO and General Counsel has exacerbated investor worries regarding corporate governance and financial health, leading to a decline in market confidence.
- Stock Price Plunge: Following the news of the lawsuit and financial issues, Kyndryl's stock price plummeted by 55%, dropping $12.90 per share to close at $10.59, reflecting a pessimistic outlook among investors regarding the company's future prospects.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation is facing a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant capital expenditure increases, which could severely impact its debt and credit rating, with investor losses expected to exceed $50,000.
- Paysafe Risks: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client in its e-commerce business, which is likely to negatively impact its revenue growth and may prevent it from meeting its financial guidance for fiscal year 2025.
- Inovio Pharmaceuticals Issues: Inovio Pharmaceuticals, Inc. is facing a class action lawsuit for the period from October 10, 2023, to December 26, 2025, due to deficiencies in manufacturing its CELLECTRA device, which is expected to hinder its ability to submit the INO-3107 BLA to the FDA by the second half of 2024, affecting its regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings, Inc. is being sued for the period from August 7, 2024, to February 9, 2026, due to materially misstated financial statements, which are expected to prevent timely filing of its Quarterly Report for the quarter ended December 31, 2025, raising concerns about its business outlook.
See More
Kyndryl Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Kyndryl, alleging securities fraud by the company and certain executives, with investors needing to apply as lead plaintiffs by April 13, 2026, indicating significant legal risks for the firm.
- Delayed Financial Reporting: On February 9, 2026, Kyndryl notified the SEC via Form 12b-5 that it could not file its 10-Q report for Q4 2025 on time, revealing an ongoing investigation into its financial reporting, which could undermine investor confidence.
- Frequent Executive Changes: On the same day, Kyndryl announced the immediate departures of CFO David Wyshner and General Counsel Edward Sebold, along with a role change for Senior VP Vineet Khurana, suggesting potential instability in the company's strategic direction due to high turnover.
- Stock Price Plummets: Following these announcements, Kyndryl's stock price fell by $12.90, or 55%, closing at $10.59 per share, reflecting extreme pessimism in the market regarding the company's future prospects, which may adversely affect its financing and operational capabilities.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, including inadequate internal controls, which led to the inability to timely file its Quarterly Report for the quarter ending December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong reputation in the field.
- Investor Selection Advice: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation in the class action.
See More
Kyndryl Holdings Shareholder Class Action Notice
- Class Action Notice: The Gross Law Firm has issued a notice to shareholders of Kyndryl Holdings, Inc. (NYSE:KD), encouraging those who purchased shares during the class period from August 7, 2024, to February 9, 2026, to contact the firm regarding potential lead plaintiff appointment for recovery.
- Financial Misstatements: The complaint alleges that Kyndryl's financial statements during the class period were materially misstated and that the company failed to disclose inadequate internal controls, which resulted in the inability to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025, undermining investor confidence in the company's prospects.
- Registration Deadline: Shareholders must register by April 13, 2026, to participate in the class action, and upon registration, they will be enrolled in a portfolio monitoring software to receive status updates throughout the case lifecycle, ensuring investors stay informed.
- Law Firm Background: The Gross Law Firm is a nationally recognized class action law firm committed to protecting the rights of investors who have suffered losses due to deceit and illegal business practices, emphasizing the importance of responsible business practices and good corporate citizenship.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, lacked adequate internal controls, and failed to timely file its Quarterly Report for the quarter ending December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
